Kenvue Inc. (KVUE)
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
- Ticker
- KVUE
- Exchange
- NYSE
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Market cap
- $37.09B
- 52-week range
- $14.02 - $20.13
Valuation
- Share price
- $19.31 (close of Oct 30, 2026)
- P/E (TTM)
- 21.94x
- Price to book
- 3.65x
- Price to free cash flow
- 15.86x
- Enterprise value
- $44.39B
- Book value per share
- $5.29
Price performance
| Period | Change |
|---|---|
| 1 day | -1.28% |
| 5 days | -1.33% |
| 1 month | +9.34% |
| 3 months | 0.00% |
| 6 months | +10.15% |
| Year to date | +11.94% |
| 1 year | +35.60% |
| 3 years | +3.59% |
| All time | -28.22% |
Short interest
- As of
- Oct 15, 2026
- Short % of float
- 3.36%
- Shares short
- 55.70M
- Days to cover
- 2.71
- Change since prior report
- -3.41%
- Source
- FINRA consolidated short interest
Members of Congress who disclosed KVUE trades
Gilbert Ray Cisneros · Lisa McClain · Julia Letlow · Kevin Hern · Val Hoyle · Alan Armstrong · Scott Franklin · Sheldon Whitehouse
Super investors holding KVUE
Ken Griffin (Citadel) · Yacktman Asset Mgmt (Yacktman Asset Management LP) · George Soros (Soros Fund Mgmt) · Ray Dalio (Bridgewater Associates) · Lee Ainslie (Maverick Capital LTD) · Tweedy Browne (Tweedy Browne Company LLC)
Profitability and growth
- Return on equity
- 13.66%
- Return on invested capital
- 9.70%
- Return on assets
- 5.43%
- Return on capital employed
- 11.42%
- Gross margin
- 58.13%
- Net margin
- 9.72%
- EBITDA margin
- 19.64%
- Revenue growth
- -2.14%
- Net income growth
- 42.72%
- Free cash flow growth
- 28.99%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 6.30%
- Current ratio
- 0.96x
- Net debt to EBITDA
- 2.21x
Latest reported year
- Period end
- Dec 28, 2025
- Fiscal year
- 2025
- Revenue
- $15.12B
- Cost of revenue
- $6.33B
- Gross profit
- $8.79B
- EBITDA
- $2.97B
- Net income
- $1.47B
- Earnings per share
- $0.77
- Research and development
- $382.00M
- Interest expense
- $379.00M
- Shares outstanding
- 1.92B
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|---|---|---|---|
| 2025-12-28 | $15.12B | $8.79B | $1.47B | $0.77 |
| 2024-12-29 | $15.46B | $8.96B | $1.03B | $0.54 |
| 2023-12-31 | $15.44B | $8.64B | $1.66B | $0.90 |
| 2023-01-01 | $14.95B | $8.29B | $2.06B | $1.20 |
| 2022-01-02 | $15.05B | $8.42B | $2.08B | $1.21 |
| 2020-12-31 | $14.47B | $7.85B | -$879.00M | - |
| 2019-12-31 | $14.32B | $7.66B | $1.44B | - |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-28 | 58.13% | 9.72% | 13.66% | 9.70% |
| 2024-12-29 | 57.97% | 6.66% | 10.65% | 7.92% |
| 2023-12-31 | 55.96% | 10.77% | 14.84% | 10.11% |
| 2023-01-01 | 55.42% | 13.81% | 10.34% | 10.47% |
| 2022-01-02 | 55.93% | 13.80% | 10.19% | - |
| 2020-12-31 | 54.25% | -6.08% | -4.79% | - |
| 2019-12-31 | 53.49% | 10.02% | - | - |
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-28 | $1.06B | - |
| 2024-12-29 | $1.07B | - |
| 2023-12-31 | $1.38B | $7.69B |
| 2023-01-01 | $1.23B | - |
| 2021-12-31 | $740.00M | - |
| 2020-12-31 | $618.00M | - |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-28 | $1.72B | $136.00M |
| 2024-12-29 | $1.33B | $254.00M |
| 2023-12-31 | $2.70B | $188.00M |
| 2023-01-01 | $2.15B | $137.00M |
| 2022-01-02 | $39.00M | $141.00M |
| 2020-12-31 | $3.17B | $115.00M |
| 2019-12-31 | $2.71B | $102.00M |
Dividend history
- Most recent payment
- Sep 21, 2026
- Paid in the last twelve months
- $0.21
| Payment date | Dividend per share |
|---|---|
| 2026-09-21 | $0.21 |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-10-30 | Sep 2026 | $0.28 |
| 2026-08-06 | Jun 2026 | $0.32 |
| 2026-05-07 | Mar 2026 | $0.27 |
| 2026-02-17 | Dec 2025 | $0.22 |
| 2025-11-03 | Sep 2025 | $0.27 |
| 2025-08-07 | Jun 2025 | $0.28 |
| 2025-05-08 | Mar 2025 | $0.22 |
| 2025-02-06 | Dec 2024 | $0.26 |
Filings and sources
- Company website
- kenvue.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Kimberly-Clark Corp (KMB) · Estee Lauder Companies Inc (EL) · Church & Dwight Co Inc (CHD) · Colgate-Palmolive Co (CL) · Clorox Co (CLX) · Procter & Gamble Co (PG) · e.l.f. Beauty, Inc. (ELF) · BJ's Wholesale Club Holdings, Inc. (BJ)
All Consumer Defensive companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades